Synonyms:Benzo[a]phenothiazin-7-ium,9-(diethylamino)-5-(ethylamino)-, chloride (9CI)
The study focuses on the development of a light-activated construct for the destruction of methicillin-resistant Staphylococcus aureus (MRSA) by exploiting a bacterial drug-resistance mechanism. The researchers synthesized a construct, known as b-lactamase-enzyme-activated photosensitizer (b-LEAP), which is activated by light and recognizes a molecular target unique to the bacterium of interest. This approach enhances selectivity, as the construct can only be activated by light after interacting with the molecular target, potentially reducing damage to healthy host tissue. The photosensitizer used in the study was 5-(4’-carboxybutylamino)-9-diethylaminobenzo[a]phenothiazinium chloride (EtNBS-COOH), an EtNBS derivative, which was conjugated to a cephalosporin derivative, 7-amino-3-chloromethyl-3-cephem-4-carboxylic acid p-methoxybenzyl ester (ACLE), to form b-LEAP. The purpose of these chemicals was to create a system where the photosensitizer is only activated in the presence of b-lactamase, an enzyme produced by MRSA, thus targeting the bacteria specifically and enabling photodynamic therapy (PDT) to be more effective against drug-resistant infections.
What can I do for you?
Get Best Price
Total 8 Pictures about this product
